European Sovereignty Monitor

Industry, investment and R&D

UK's Research Ventures Catalyst awards GBP 82.6 million to AI health projects

The UK government committed GBP 37.9 million through its Research Ventures Catalyst programme to three projects, including PharosAI's cancer AI platform and Bind Research's drug discovery AI, drawing GBP 44.7 million co-investment for GBP 82.6 million total.

Verified AI-drafted GOV.UK press release, 11 February 2025

What it does not test. Does not establish how the funded platforms will be deployed in the NHS or whether they deliver clinical results.

How this item counts. This item is dated before the index starts on 1 January 2026, so it does not count in the European Sovereignty Index.

How this item was made. Drafted by an AI system (Claude (Anthropic)) from the source cited above and published under the editor’s responsibility without a person reading it first. How the record is made

What the tags mean: VerifiedReportedAI-draftedAI-drafted, editor-readHuman-writtenWhat the tags mean

Previously in Industry, investment and R&D

VerifiedAI-drafted ECA audit of EU research partnerships flags grant errors and ITER cost risk VerifiedAI-drafted Spain's Seaya raises EUR 600 million first close of growth fund Seaya Nova VerifiedAI-drafted Anglo-Finnish quantum spinout QuantrolOx raises EUR 12 million Series A

All Industry, investment and R&D news →